Vous êtes ici : Accueil > L'institut > Cellular and molecular aspects of extracellular vesicle uptake and content delivery


Cellular and molecular aspects of extracellular vesicle uptake and content delivery

Vendredi 07 juillet 2023 à 11:00, Salle de séminaire IBS, 71 avenue des Martyrs, Grenoble

Publié le 7 juillet 2023
Dr Gregory Lavieu
Université Paris Cité, INSERM U1316, CNRS UMR7057, Paris
Extracellular Vesicles (EVs) are now recognized as vectors of intercellular communication capable of transferring nucleotides, lipids, and proteins from donor to acceptor cells. EV-mediated communication has been associated with many physiological and pathophysiological functions, including cancer, immune responses, cardiovascular diseases, lipid homeostasis, regeneration and stem cell-based therapy. The spectrum of tissues/cells that are capable of releasing or capturing EVs is broad and includes, neuronal cells, adipocytes, as well as immune cells.
EVs are therefore being recognized as vectors of major importance for physiology in general, and appears as promising candidates for translational applications such as targeted drug delivery. Using EVs or EV mimetics to deliver therapeutics (including the gene editing toolbox) to specific cells within the body would revolutionize cell/gene therapy.
However, the delivery process mechanisms within the acceptor cells remain unknown at both cellular and molecular levels. How do vesicles enter cells ? Is it receptor-dependent ? How do vesicles deliver their contents within the cytosol of the acceptor cells ? Does it require membrane fusion ? If yes, what is the nature of the target membrane and the fusion machinery ? Those basic questions are not yet answered. This is not satisfying, especially considering how much we know about the cellular and molecular mechanisms that regulate the delivery of viruses or the transport of intracellular vesicles, which both share several physico-chemical properties with EVs.
It is therefore of high priority to close these gaps, especially when considering the high translational impact of EVs as virus-free vectors for therapeutics delivery.
​ I will present our recent efforts to assess EV uptake and content delivery in a qualitative and quantitative manner, and discuss the cellular and molecular mechanisms that are involved in this process. Then I will present our efforts to bioengineer EVs with enhanced properties to enable targeted therapeutics delivery.

L’accès au campus EPN nécessite un avis de rendez-vous.
Merci de contacter Odile Cavoret (au moins 48h à l’avance) au 04 57 42 87 04 / ibs.seminaires@ibs.fr
N’oubliez pas de vous munir d’une pièce d’identité.